A Pharmacoepidemiological Study on the Association Between Bicalutamide Treated Prostate Cancer and Risk of Coronary Heart Disease (CHD) and Heart Failure (HF) in the General Practice Research Database (GPRD)
Latest Information Update: 07 Feb 2013
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
Most Recent Events
- 24 Jun 2008 New trial record.